Cubist to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014
April 15 2014 - 8:00AM
Business Wire
Earnings Conference Call & Webcast at 5:00
pm ET
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first
quarter 2014 financial results at 4:00 p.m. ET on Tuesday, April
22, 2014. In connection with this announcement, Cubist will host a
conference call and live audio webcast presentation at 5:00 p.m. ET
that same day to discuss its first quarter financial results,
business activities, and financial outlook.
The quarterly earnings call will be available via phone and
webcast. The conference call dial-in information is listed below.
To access the webcast, please log on to the site at least 15
minutes prior to the start of the call to ensure adequate time for
any software downloads that may be required.
A replay of the webcast and teleconference will be available on
Cubist’s website beginning approximately three hours after the
call.
**************************CONFERENCE CALL &
WEBCAST INFORMATION**************************
CUBIST Q1 2014 FINANCIAL RESULTSTuesday, April
22, 2014 at 5:00 pm ET
U.S./Canada Attendee Dial-in: (855)
319-7654International Attendee Dial-in: (484) 756-4327Conference
ID: 12504774
24-HOUR REPLAY U.S./CANADA: (855)
859-205624-HOUR REPLAY INTERNATIONAL: (404) 537-3406Conference ID:
12504774
CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY,
VIA THE WEB
AT:https://cubist.webex.com/cubist/onstage/g.php?t=a&d=629311873Attendee
Password: 04222014
Replay will be available for 90 days at
www.cubist.com
*****************************************************************************************
About Cubist
Cubist Pharmaceuticals, Inc. is a global biopharmaceutical
company focused on the research, development, and commercialization
of pharmaceutical products that address significant unmet medical
needs in the acute care environment. Cubist is headquartered in
Lexington, Massachusetts, with a central international office
located in Zurich, Switzerland. Additional information can be found
at Cubist’s web site at www.cubist.com. Also, connect with Cubist
on Twitter @cubistbiopharma and @cubistcareers, LinkedIn, or
YouTube.
INVESTORS:Cubist Pharmaceuticals,
Inc.Eileen C. McIntyre,
781-860-8533eileen.mcintyre@cubist.comorMEDIA:Cubist Pharmaceuticals, Inc.Julie DiCarlo,
781-860-8063Senior Director, Corporate
Communicationsjulie.dicarlo@cubist.com